Search research articles
Contact Us
Filters
Showing results (391-400 of 484) with videos related to
Page
of 49
Sort By:
Cardiovascular Research
|
April 7, 2021
Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial
Jie Yu, Jingwei Li, Phillip J Leaver, et al.
Diabetes Care
|
March 24, 2016
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
Muh Geot Wong, Vlado Perkovic, John Chalmers, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
May 16, 2019
The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24-hour, spot, and short duration (<24 hours) timed urine collections to assess dietary sodium intake
Norm R C Campbell, Feng J He, Monique Tan, et al.
Nutrients
|
February 25, 2023
Evaluation of a Salt-Reduction Consumer Awareness Campaign Targeted at Parents Residing in the State of Victoria, Australia
Carley A Grimes, Kristy A Bolton, Karen Lim, et al.
Lancet (London, England)
|
September 1, 2021
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial
Clara K Chow, Emily R Atkins, Graham S Hillis, et al.
Heart (British Cardiac Society)
|
June 5, 2026
Changes in the metabolome after treatment with canagliflozin in patients with type 2 diabetes
Craig Peter Coorey, Owen Tang, Mengbo Li, et al.
Heart (British Cardiac Society)
|
August 9, 2022
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis
Xuejun Yin, Anthony Rodgers, Adam Perkovic, et al.
European Journal of Preventive Cardiology
|
March 6, 2016
Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease
Vanessa Selak, Chris Bullen, Sandrine Stepien, et al.
Journal of Hypertension
|
May 21, 2010
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial
Toshiharu Ninomiya, Sophia Zoungas, Bruce Neal, et al.
Journal of the American Society of Nephrology : JASN
|
May 16, 2009
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
Toshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, et al.
Page
of 49
Search research articles
Search
Showing results (391-400 of 484) with videos related to
Sort By:
Page
of 49
Cardiovascular Research
|
April 7, 2021
Effects of canagliflozin on myocardial infarction: a post hoc analysis of the CANVAS programme and CREDENCE trial
Jie Yu, Jingwei Li, Phillip J Leaver, et al.
Diabetes Care
|
March 24, 2016
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
Muh Geot Wong, Vlado Perkovic, John Chalmers, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
May 16, 2019
The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24-hour, spot, and short duration (<24 hours) timed urine collections to assess dietary sodium intake
Norm R C Campbell, Feng J He, Monique Tan, et al.
Nutrients
|
February 25, 2023
Evaluation of a Salt-Reduction Consumer Awareness Campaign Targeted at Parents Residing in the State of Victoria, Australia
Carley A Grimes, Kristy A Bolton, Karen Lim, et al.
Lancet (London, England)
|
September 1, 2021
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial
Clara K Chow, Emily R Atkins, Graham S Hillis, et al.
Heart (British Cardiac Society)
|
June 5, 2026
Changes in the metabolome after treatment with canagliflozin in patients with type 2 diabetes
Craig Peter Coorey, Owen Tang, Mengbo Li, et al.
Heart (British Cardiac Society)
|
August 9, 2022
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis
Xuejun Yin, Anthony Rodgers, Adam Perkovic, et al.
European Journal of Preventive Cardiology
|
March 6, 2016
Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease
Vanessa Selak, Chris Bullen, Sandrine Stepien, et al.
Journal of Hypertension
|
May 21, 2010
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial
Toshiharu Ninomiya, Sophia Zoungas, Bruce Neal, et al.
Journal of the American Society of Nephrology : JASN
|
May 16, 2009
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
Toshiharu Ninomiya, Vlado Perkovic, Bastiaan E de Galan, et al.
Page
of 49